Symrise, DE000SYM9999

Symrise stock holds steady as analyst call supports double-digit year-to-date gains

Published on 08/29/2026 at 10:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Symrise stock benefits from a supportive analyst view and double-digit year-to-date performance, while investors weigh sector risks from an ongoing fragrance price-fixing case.

Trading-Floor mit Kurscharts und Chemiesymbolen auf Bildschirmen, Symrise AG DE000SYM9999
Symrise AG (DE000SYM9999) Börsen-Editorial zeigt Trading-Floor mit Charts und Chemie-Sektor-Symbolen auf Bildschirmen, Illustration mit AI erstellt.

Symrise AG stock (DE000SYM9999) is trading with solid year-to-date gains supported by a positive analyst stance, as investors on August 29, 2026 weigh both the company’s defensive profile and ongoing legal headwinds in the global fragrance ingredients sector.

Market data as of August 29, 2026 show Symrise shares quoted at EUR 92.88 on the Tradegate platform, with a 5-day performance of +1.09% and a year-to-date gain of 33.12%, underscoring the stock’s strong run in 2026. This market overview also indicates a 1st January performance of +3.03%, highlighting that most of the upside was generated after the early weeks of the year.

Analyst support and recent trading context

An analyst call reported on August 28, 2026 reaffirmed an overweight stance on Symrise with a price target of EUR 100, signaling confidence in the company’s earnings and growth trajectory despite broader market volatility. The commentary framed the overweight rating and EUR 100 target as unchanged after a recent investor event, suggesting that management’s presentation has not shaken the positive view from the analyst community.

Against that backdrop, Symrise shares’ current level of EUR 92.88 as of August 29, 2026 sits below the cited EUR 100 target, implying roughly 7.7% upside potential if the stock were to close the gap to the target. With a year-to-date performance of 33.12%, investors are now weighing whether the remaining upside is justified by fundamentals and sector dynamics, or whether the rally has already priced in most of the near-term positive news flow.

Recent trading across European equities on August 28, 2026 showed Symrise among the names posting gains between 1% and 2.3% in a session where German blue chips moved higher after a major central bank speech. A European market wrap listed Symrise alongside several German peers that advanced during that trading day, showing that the stock continues to participate in broader sector moves rather than trading in isolation.

Sector headwinds from fragrance price-fixing case

While the share price performance and analyst stance appear supportive, investors cannot ignore the legal overhang facing key fragrance-ingredient manufacturers. A detailed report dated August 29, 2026 describes how a New Jersey federal court granted preliminary approval on August 4 to a $33 million settlement involving DSM-Firmenich in an antitrust case that accuses four leading fragrance-ingredient makers, including Symrise, of conspiring to fix prices between January 1, 2018 and April 18, 2023. The legal dispatch explains that DSM-Firmenich agreed to settle and assist plaintiffs in prosecuting the case against the remaining defendants, while another industry player had earlier settled for $11 million.

The alleged overcharge in that case was embedded in fragrance compounds used widely across cosmetics, perfumes, candles, soaps, lotions and detergents, sectors where Symrise has long been a major supplier. The reporting period for the alleged conduct, ending on April 18, 2023, puts the legal risk squarely in the rear-view mirror in terms of operational behavior, yet the financial and reputational consequences may still unfold over coming quarters as the litigation progresses against the non-settling parties.

For investors, the key numerical comparison emerges between the modest $33 million settlement already agreed by one defendant and the potential exposure Symrise could face if courts were to determine similar levels of overcharge and damages. While no concrete figure has yet been attached publicly to Symrise’s potential liability in the case, the scale of the settlement and the breadth of products cited underscore that any resolution could be meaningful in absolute terms, even if ultimately manageable relative to the company’s global revenue base.

Consensus view and performance gap to target

The same market-consensus overview that lists Symrise’s EUR 92.88 quote and 33.12% year-to-date performance also points to a supportive analyst environment, with the overweight rating and EUR 100 price target signaling confidence in the company’s medium-term prospects. At the current level, the difference between the share price and the target translates into a gap of EUR 7.12, so investors can quantify the potential return against the stock’s recent volatility and sector risk profile.

From a performance standpoint, the contrast between the 5-day gain of 1.09% and the full-year increase of 33.12% suggests that the bulk of the share price appreciation came earlier in 2026, with recent weeks characterized more by consolidation than by sharp moves. In a market where some European consumer and chemical names have lagged, Symrise’s double-digit advance underscores the appeal of its diversified portfolio of taste, nutrition, fragrance and cosmetic ingredients, but also raises the question of whether valuation now embeds a premium relative to peers that might compress if legal risks intensify.

Analyst support after a recent investor event indicates that management has been able to articulate a strategy and a pipeline that resonates with institutional investors, even as the legal environment remains challenging. While details of the event’s financial guidance are not visible in the available sources, the maintained overweight rating and unchanged EUR 100 target point to an expectation of continued earnings growth and resilience across key segments rather than a marked downgrade of the outlook.

Operations in flavors, fragrances and natural extracts

Operationally, Symrise is characterized in sector research as a large multinational headquartered in Holzminden, Germany, with a focus on flavors, fragrances and natural extracts, including tannins. One industry outlook that maps the tannin extract additive market lists Symrise among notable providers of tannin extracts for beverage applications, reinforcing the company’s position as a supplier of specialized ingredients rather than generic commodities. The market outlook identifies Symrise’s scale and product focus as differentiators in a niche where quality and consistency are critical.

In addition to beverage-related tannin extracts, Symrise’s operations span taste, nutrition and health as well as scent and care, supplying flavorings, cosmetic base materials, active ingredients and functional solutions across regions including Europe, Africa, the Middle East, North America, Asia Pacific and Latin America. Segment descriptions emphasize how the scent and care business develops and produces fragrance ingredients and compositions, aroma molecules, cosmetic ingredients and mint flavors, along with specific application processes tailored for manufacturers of perfumes, personal care products, cleaning products, detergents, air fresheners and oral care products.

The breadth of this portfolio provides a buffer against volatility in any single end-market and allows Symrise to cross-leverage innovations, such as new fragrance molecules or natural extracts, across multiple applications. However, the same breadth also means that any legal or regulatory scrutiny of fragrance pricing practices can have wide-ranging implications, affecting perceptions among consumer-goods clients and potentially influencing contract negotiations and future volumes.

Representative product: fragrance and flavor solutions

A representative product category for Symrise is its integrated fragrance and flavor solutions for beverages and personal care, where tannin extracts, aroma molecules and tailored compositions combine to deliver a specific sensory profile. In beverage applications, for example, tannin extracts sourced and refined by Symrise are used to adjust mouthfeel, structure and perceived dryness in drinks ranging from teas to alcoholic beverages, while accompanying flavor formulations ensure that aroma and taste remain balanced.

On the personal care side, Symrise’s fragrance ingredients and compositions help define the signature scent of cosmetics, lotions, soaps and shampoos, working together with functional ingredients that stabilize formulations and maintain performance over shelf life. This blend of creative perfumery and technical formulation expertise allows the company to move beyond simple commodity suppliers, positioning itself as a partner for brand owners that seek distinctive sensory experiences tailored to their target demographics and geographies.

Symrise stock and current trading level

Symrise stock is primarily listed in Germany, where the shares were quoted at EUR 92.88 on Tradegate as of August 29, 2026, with a 5-day performance of +1.09% and a year-to-date gain of 33.12% according to consolidated market data. At this level, the stock trades below the cited EUR 100 analyst price target but above earlier-year levels, reflecting both the strong run-up in 2026 and the remaining implied upside that supporters of the investment case see.

For investors, the combination of solid year-to-date performance, supportive analyst commentary and an ongoing sector antitrust case creates a nuanced picture. Symrise’s diversified operations in flavors, fragrances and natural extracts, including tannin solutions for beverages and fragrance ingredients for personal care, underpin the earnings profile that supports the current valuation. At the same time, the unresolved legal process around alleged price-fixing between January 1, 2018 and April 18, 2023 adds a layer of uncertainty that could influence risk assessments and position sizing in portfolios, particularly if further settlements or judgments bring new financial figures into view.

Read more

Further context on Symrise’s stock performance and market consensus is available via dedicated quote and analysis pages that track the EUR 92.88 share price level, short-term changes and the 33.12% year-to-date gain as of August 29, 2026, alongside the overweight rating and EUR 100 price target.

Symrise AG key ingredients supplier

Symrise AG is a large multinational headquartered in Holzminden, Germany, supplying flavors, fragrances, natural extracts and cosmetic ingredients to beverage, food, cosmetic, home-care and oral-care manufacturers worldwide.

Symrise AG stock data

Company: Symrise AG
ISIN: DE000SYM9999
Ticker: SYM
Exchange: German listing (Tradegate and other German venues)
Price (as of August 29, 2026): EUR 92.88
Market cap: Not specified in available quote sources
Sector / Industry: Flavors and fragrances, consumer ingredients
Index membership: German equities universe

Disclaimer...

en | DE000SYM9999 | SYMRISE | boerse | 70019204 | bgmi